Soyoligosaccharide increases fecal bifidobacteria counts, short-chain fatty acids, and fecal lipid concentrations in young Korean women

Journal of Medicinal Food

Volumn 10, Issue 2, 2007, Pages 366-370

  Myung, Hee Bang ^a   Ok, Suk Chio ^a   Woo, Kyoung Kim ^a  

^a Dankook University   (South Korea)

Author keywords

Bifidobacteria; Fecal lipid profile; Short chain fatty acid; Soyoligosaccharide

Indexed keywords

BUTYRIC ACID; LIPID; OLIGOSACCHARIDE; PROPIONIC ACID; SHORT CHAIN FATTY ACID; SOYOLIGOSACCHARIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL COUNT; BIFIDOBACTERIACEAE; CARBOHYDRATE INTAKE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FATTY ACID ANALYSIS; FECES ANALYSIS; FECES MICROFLORA; FEMALE; HUMAN; HUMAN EXPERIMENT; KOREA; LIPID ANALYSIS; LIPID METABOLISM; NORMAL HUMAN; PH MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WATER CONTENT;

ADULT; BIFIDOBACTERIUM; COLONY COUNT, MICROBIAL; FATTY ACIDS, VOLATILE; FECES; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; KOREA; LIPIDS; OLIGOSACCHARIDES; SOYBEANS; WATER;

EID: 34547127159     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2005.096     Document Type: Article

References (23)

1. Cummings JH, Macfarlane GT, Englyst HN: Prebiotic digestion and fermentation. Am J Clin Nutr 2001;73(Suppl)415S-420S.
2. Gibson GR, Roberfroib MB: Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995;125:1401-1412.
3. Vogt JA, Wolever TM: Fecal acetate is inversely related to acetate absorption from the human rectum and distal colon. J Nutr 2003;133:3145-3148.
4. Holt PR, Atillasoy E, Lindenbaum J, Ho SB, Lupton JR, McMahon D, Moss SF: Effects of acarbose on fecal nutrients, colonic pH, and short-chain fatty acids and rectal proliferative indices. Metabolism 1996;45:1179-1187.
5. Griffiths EA, Duffy LC, Schanbacher FL, Qiao H, Dryja D, Leavens A, Rossman J, Rich G, Dirienzo D, Ogra PL: In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice. Dig Dis Sci 2004;49:579-589.
6. Sekine K, Ohta J, Onishi M, Tatsuki T, Shimokawa Y, Toda T, Kawashima T, Hashimoto Y: Analysis of antitumor properties of effector cells stimulated with a cell wall preparation (WPG) of Bifidobacterium infantis. Biol Pharm Bull 1995;18:148-153.
7. Chung MG, Lee JC: Functional characteristics of soybean oligosaccharide. Korea J Crop Sci 2003;48:58-64.
8. Yosushi K, Takanbu S, Robert O: Soybean oligosaccharides. In: Oligosaccharides: Production, Properties and Applications, Japanese Technology Reviews 3(2) (Nakakuki T, ed.), Gordon and Breach Science Publishers, Tokyo, 1993, pp. 176-203.
9. Kim WK, Chung MK, Kim MH, Park OJ: Effect of resistant starch from corn or rice on glucose control, colonic events, and blood lipid concentrations in streptozotocin-induced diabetic rat. J Nutr Biochem 2003;14:497-509.
10. Folch JM, Lees G, Stanley HS: A simple method for the isolation, and purification of total lipids from animal tissues. J Biol Chem 1957;223:497-509.
11. Frings CS, Dunn RT: A colorimetric method for determination of total serum lipids based on the sulfphosphovanillin reaction. Am J Clin Pathol 1970;53:89-91.
12. Zak B: Total and free cholesterol. In: Standard Method Chemistry (Seligson B, ed.), Academic Press, New York, 1968, pp. 79-89.
13. Grizard D, Barthomeuf C: Non-digestible oligosaccharides used as prebiotic agent: mode of production and beneficial effects on animal and human health. Reprod Nutr Dev 1999;39:563-588.
14. Gilson GR, Roberfroid MB: Dietary modulation of human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995;125:1401-1412.
15. Bouhnik Y, Raskine L, Simoneau G, Vicaut E, Neut C, Flourie B, Brouns F, Bornet FR: The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study. Am J Clin Nutr 2004;80:1658-1664.
16. Gilson GR: Dietary modulation of the human gut microflora using prebiotics. Br J Nutr 1998;80(Suppl):S209-S212.
17. Delzenne NM: Oligosaccharides: state of the art. Proc Nutr Soc 2003;62:177-182.
18. Scheppach W, Bartram P, Richter A, Richter F, Liepold H, Dusel G, Hofstetter G, Ruthlein J, Kasper H: Effect of short-chain fatty acids on the human colonic mucosa in vitro. JPEN J Parenter Enteral Nutr 1992;16:43-48.
19. Flickinger EA, Hatch TF, Wofford RC, Grieshop CM, Murray SM, Fahey GC Jr: In vitro fermentation properties of selected fructooligosaccharide-containing vegetables and in vivo colonic microbial populations are affected by the diets of healthy human infants. J Nutr 2002;132:2188-2194.
20. Archer S, Meng S, Wu J, Johnson J, Tang R, Hodin R: Butyrate inhibits colon carcinoma cell growth through two distinct pathways. Surgery 1998;124:248-253.
21. Kapadia SA, Raimundo AH, Grimble GK, Aimer P, Silk DB: Influence of three different fiber-supplemented enteral diets on bowel function and short-chain fatty acid production. JPEN J Parenter Enteral Nutr 1995;19:63-68.
22. Gibson GR: Fiber and effects on prebiotics (the prebiotic concept). Clin Nutr Suppl 2004;1:25-31.
23. Delzenne NM, Williams CM: Prebiotics and lipid metabolism. Curr Opin Lipidol 2002;13:61-67.